US Activist Hedge Fund Institutional SEC 13D 13G — September 02, 2026
This digest of 48 filings reveals a bifurcated activist landscape: aggressive, high-conviction moves by major holders like Advent International (Definitive Healthcare) and Saba Capital (BlackRock ESG Term Trust) contrast with passive institutional stake-building in ETFs and infrastructure funds. The most critical development is the potential take-private of Definitive Healthcare at $1.02/share, a 58.5% holder-led bid with insider rollover, signaling deep value. A significant pattern emerges in the SPAC and blank-check space, with three separate filers (Great Point, Deep Track, Commodore) all accumulating 5-6% passive stakes in JATT III Acquisition Corp, suggesting a coordinated or thematic bet on a deSPAC catalyst. Insider selling is notable but largely explained by estate planning (Tutor Perini) and warrant restructuring (Carvana/Root). The withdrawal of TDS's proposal to acquire Array's remaining shares is a major strategic reversal, creating uncertainty for minority holders. Capital allocation is mixed, with a $7.7M preferred equity injection into Valion Bio (Tivic Health) and a $55M structured investment in Accuray with significant execution risk. Overall, the data points to a market where large holders are forcing action (go-private bids, board engagement) while passive investors rotate into defined-outcome ETFs and infrastructure, signaling a risk-off tilt within the active opportunity set.